Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12652570rdf:typepubmed:Citationlld:pubmed
pubmed-article:12652570lifeskim:mentionsumls-concept:C0694884lld:lifeskim
pubmed-article:12652570lifeskim:mentionsumls-concept:C0600507lld:lifeskim
pubmed-article:12652570lifeskim:mentionsumls-concept:C0026377lld:lifeskim
pubmed-article:12652570lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:12652570lifeskim:mentionsumls-concept:C1513778lld:lifeskim
pubmed-article:12652570lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:12652570lifeskim:mentionsumls-concept:C0657019lld:lifeskim
pubmed-article:12652570pubmed:issue1-2lld:pubmed
pubmed-article:12652570pubmed:dateCreated2003-3-24lld:pubmed
pubmed-article:12652570pubmed:abstractTextFor facilitated genotypic analysis of multiple endocrine neoplasia type 1 (MEN1), a familial syndrome associated with tumors of the parathyroid and neuroendocrine tissues, we developed two screening methods, heteroduplex mutation assay (HMA) and mutation detection gel analysis (MDGA), both based on electrophoretic discrimination of polymerase chain reaction (PCR) products, to detect the mutations. Forty-three genomic DNA samples were used for the evaluation of these techniques. The whole coding region of MEN1 was PCR-amplified with fluorescent primers and then denatured/renatured before electrophoresis on an automated sequencer. 100% of the mutations were detected, subsequently confirmed and identified by sequencing. "Negative" samples were used to evaluate the specificity and reproducibility of the two techniques. The combination of the two methods allows high throughput cost-effective mutation screening which is less laborious than systematic sequencing of the whole coding region of MEN1. Together, these methods provide an efficient screen for MEN1 mutations.lld:pubmed
pubmed-article:12652570pubmed:languageenglld:pubmed
pubmed-article:12652570pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12652570pubmed:citationSubsetIMlld:pubmed
pubmed-article:12652570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12652570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12652570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12652570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12652570pubmed:statusMEDLINElld:pubmed
pubmed-article:12652570pubmed:monthJanlld:pubmed
pubmed-article:12652570pubmed:issn0173-0835lld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:PignyPascalPlld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:CalenderAlain...lld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:CrépinMichelMlld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:EscandeFabien...lld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:PorchetNicole...lld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:BuisineMarie-...lld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:OdouMarie-Fra...lld:pubmed
pubmed-article:12652570pubmed:authorpubmed-author:Groupe...lld:pubmed
pubmed-article:12652570pubmed:issnTypePrintlld:pubmed
pubmed-article:12652570pubmed:volume24lld:pubmed
pubmed-article:12652570pubmed:ownerNLMlld:pubmed
pubmed-article:12652570pubmed:authorsCompleteYlld:pubmed
pubmed-article:12652570pubmed:pagination26-33lld:pubmed
pubmed-article:12652570pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:meshHeadingpubmed-meshheading:12652570...lld:pubmed
pubmed-article:12652570pubmed:year2003lld:pubmed
pubmed-article:12652570pubmed:articleTitleEfficient mutation detection in MEN1 gene using a combination of single-strand conformation polymorphism (MDGA) and heteroduplex analysis.lld:pubmed
pubmed-article:12652570pubmed:affiliationSecteur Oncologie Moléculaire Huriez-USN, Laboratoire de Biochimie et Biologie Moléculaire, CHRU, Lille, France.lld:pubmed
pubmed-article:12652570pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12652570pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12652570lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12652570lld:pubmed